Bahrain vs Peru: The number of people with susceptibility test result for rifampicin
Bahrain
94.12
in 2021
Peru
94.02
in 2021
Bahrain rank
54th
Peru rank
55th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Peru
How they compare
Bahrain currently reports 94.12 against 94.02 in Peru, a difference of 0.1.
Across all 5 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 54th and Peru ranks 55th of 146 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.36 | 76.94 | 20.42 | Bahrain |
| 2020s | 86.48 | 82.99 | 3.49 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Peru?
- Bahrain, at 94.12 against 94.02 in Peru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Peru?
- 0.1, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Peru?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Peru rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 54th and Peru ranks 55th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.